Notice of Participation of NIDA in PAR-15-189 "Lasker Clinical Research Scholars Program Si2/R00"

Notice Number: NOT-DA-15-070

Key Dates
Release Date:   May 21, 2015

Related Announcements
PAR-15-189

Issued by
National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this Notice is to inform potential applicants that the National Institute on Drug Abuse (NIDA) is participating, effective immediately, in PAR-15-189, "Lasker Clinical Research Scholars Program Si2/R00."

The following sections of PAR-15-189 have been updated to reflect the participation of NIDA in this FOA.

Part 1. Overview Information

 Components of Participating Organizations
National Cancer Institute (NCI)
National Eye Institute (NEI)
National Heart, Lung, and Blood Institute (NHLBI)
National Human Genome Research Institute (NHGRI)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute on Drug Abuse (NIDA)
National Institute of Environmental Health Sciences (NIEHS)
National Institute of Mental Health (NIMH)
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute of Nursing Research (NINR)

Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.140; 93.233; 93.839; 93.838; 93.837; 93.853; 93.846; 93.856; 93.279; 93.855; 93.113; 93.847; 93.398; 93.395; 93.394; 93.393; 93.242; 93.865; 93.361; 93.172; 93.867

Section VII.  Agency Contacts

Scientific/Research Contact(s)
Dr. Antonello Bonci     
National Institute on Drug Abuse (NIDA)
Telephone: 443-740-2463
Email: boncia@mail.nih.gov

All other sections of this FOA remain the same.

Inquiries

Dr. Antonello Bonci     
National Institute on Drug Abuse (NIDA)
Telephone: 443-740-2463
Email: boncia@mail.nih.gov